Cargando…

PIM2 induced MMP-9 expression in macrophages requires PI3K and Notch1 signaling

Detalles Bibliográficos
Autores principales:	Kapoor, Nisha, Bansal, Kushagra, Puzo, Germain, Gilleron, Martine, Balaji, KN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508815/ http://dx.doi.org/10.1186/1479-5876-10-S3-P23

Ejemplares similares

PIM2 Induced COX-2 and MMP-9 Expression in Macrophages Requires PI3K and Notch1 Signaling
por: Bansal, Kushagra, et al.
Publicado: (2009)

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2019)

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC
por: Moore, Gillian, et al.
Publicado: (2021)

Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro
por: Lelongt, Brigitte, et al.
Publicado: (1997)

Design of the Pi-Mode Structure (PIMS) for Linac4
por: Gerigk, F, et al.
Publicado: (2009)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
por: Aziz, Aziz Ur Rehman, et al.
Publicado: (2018)

Tuning procedure for the Linac4 PI Mode Structure(PIMS)
por: Ugena Tirado, P, et al.
Publicado: (2012)

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
por: Mohlin, Sofie, et al.
Publicado: (2019)

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
por: Mohlin, Sofie, et al.
Publicado: (2020)

Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells
por: Santio, Niina M., et al.
Publicado: (2016)

KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA
por: Cheng, Fang, et al.
Publicado: (2009)

xtalPiMS: A PiMS-based web application for the management and monitoring of crystallization trials
por: Daniel, Ed, et al.
Publicado: (2011)

PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion
por: Landor, Sebastian K.J., et al.
Publicado: (2021)

Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition
por: Iqbal, Asneha, et al.
Publicado: (2016)

Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer
por: Kennedy, Sean P., et al.
Publicado: (2020)

SCF increases cardiac stem cell migration through PI3K/AKT and MMP-2/-9 signaling
por: GUO, JUNLI, et al.
Publicado: (2014)

SCF increases cardiac stem cell migration through PI3K/AKT and MMP-2/-9 signaling
por: Guo, Junli, et al.
Publicado: (2022)

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
por: Santio, Niina M, et al.
Publicado: (2010)

The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition
por: Mologni, Luca, et al.
Publicado: (2017)

Notch, metabolism and macrophages
por: Xu, Jun, et al.
Publicado: (2015)

Igβ ubiquitination activates PI3K signals required for endosomal sorting
por: Veselits, Margaret, et al.
Publicado: (2017)

Diacylated Sulfoglycolipids Are Novel Mycobacterial Antigens Stimulating CD1-restricted T Cells during Infection with Mycobacterium tuberculosis
por: Gilleron, Martine, et al.
Publicado: (2004)

Lipoteichoic Acid in Streptomyces hygroscopicus: Structural Model and Immunomodulatory Activities
por: Cot, Marlène, et al.
Publicado: (2011)

Macrophage-Activating Lipopeptide-2 Requires Mal and PI3K for Efficient Induction of Heme Oxygenase-1
por: You, Xiaoxing, et al.
Publicado: (2014)

Linac4 PIMS
por: Pantelia, Anna
Publicado: (2014)

The role of PIM1/PIM2 kinases in tumors of the male reproductive system
por: Jiménez-García, Manuel Pedro, et al.
Publicado: (2016)

PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Wang, Jun-Cheng, et al.
Publicado: (2022)

Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
por: Wang, Jie, et al.
Publicado: (2011)

Multicenter validation of PIM3 and PIM2 in Brazilian pediatric intensive care units
por: Genu, Daniel Hilário Santos, et al.
Publicado: (2022)

8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells
por: Wu, Pei-Shan, et al.
Publicado: (2021)

Macrophage morphological plasticity and migration is Rac signalling and MMP9 dependant
por: Travnickova, Jana, et al.
Publicado: (2021)

eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants
por: Chen, Ke, et al.
Publicado: (2016)

Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cells
por: Litchfield, Lacey M., et al.
Publicado: (2020)

AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor
por: Ingle, Komala, et al.
Publicado: (2023)

Dama de Porto Pim /
por: Tabucchi, Antonio, 1943-2012
Publicado: (1984)

El Pim-pam-pum
por: Ionesco, Eugène

Dama de Porto Pim
por: Tabucchi, Antonio 1943-
Publicado: (1997)

PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Notch Signaling Regulates MMP-13 Expression via Runx2 in Chondrocytes
por: Xiao, Di, et al.
Publicado: (2019)

Suppressive neutrophils require PIM1 for metabolic fitness and survival during chronic viral infection
por: Volberding, Peter J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2brhei8qbcf5lnkp9bggvqiqh6